TY - JOUR
T1 - Correction
T2 - Efficacy of liposomal irinotecan + 5-FU/LV vs. S-1 in gemcitabine-refractory metastatic pancreatic cancer: a real-world study using inverse probability of treatment weighting (Journal of Gastroenterology, (2024), 10.1007/s00535-024-02186-9)
AU - the Japan Oncology Network in Hepatobiliary and Pancreas
AU - Imaoka, Hiroshi
AU - Ikeda, Masafumi
AU - Kobayashi, Satoshi
AU - Ohba, Akihiro
AU - Ueno, Masayuki
AU - Suzuki, Yuko
AU - Tsumura, Hidetaka
AU - Kimura, Nana
AU - Kawaguchi, Shinya
AU - Kawamoto, Yasuyuki
AU - Nakachi, Kohei
AU - Tsuji, Kunihiro
AU - Kobayashi, Noritoshi
AU - Ashida, Reiko
AU - Okano, Naohiro
AU - Umemoto, Kumiko
AU - Murohisa, Gou
AU - Hosokawa, Ayumu
AU - Asagi, Akinori
AU - Nebiki, Hiroko
AU - Suzuki, Rei
AU - Terashima, Takeshi
AU - Shibata, Ryusuke
AU - Kawata, Kazuhito
AU - Doi, Toshifumi
AU - Ohyama, Hiroshi
AU - Kitano, Yohei
AU - Shioji, Kazuhiko
AU - Okuyama, Hiroyuki
AU - Naganuma, Atsushi
AU - Negoro, Yuji
AU - Sakamoto, Yasunari
AU - Shimizu, Satoshi
AU - Morizane, Chigusa
AU - Ueno, Makoto
AU - Furuse, Junji
AU - Nagano, Hiroaki
N1 - Publisher Copyright:
© The Author(s) 2025.
PY - 2025
Y1 - 2025
N2 - The article ‘Efficacy of liposomal irinotecan + 5‑FU/LV vs. S‑1 in gemcitabine‑refractory metastatic pancreatic cancer: a real‑world study using inverse probability of treatment weighting’, written by ‘Hiroshi Imaoka, Masafumi Ikeda, Satoshi Kobayashi, Akihiro Ohba, Masayuki Ueno, Yuko Suzuki, Hidetaka Tsumura, Nana Kimura, Shinya Kawaguchi, Yasuyuki Kawamoto, Kohei Nakachi, Kunihiro Tsuji, Noritoshi Kobayashi, Reiko Ashida, Naohiro Okano, Kumiko Umemoto, Gou Murohisa, Ayumu Hosokawa, Akinori Asagi, Hiroko Nebiki, Rei Suzuki, Takeshi Terashima, Ryusuke Shibata, Kazuhito Kawata, Toshifumi Doi, Hiroshi Ohyama, Yohei Kitano, Kazuhiko Shioji, Hiroyuki Okuyama, Atsushi Naganuma, Yuji Negoro, Yasunari Sakamoto, Satoshi Shimizu, Chigusa Morizane, Makoto Ueno, Junji Furuse, Hiroaki Nagano, the Japan Oncology Network in Hepatobiliary and Pancreas’, was originally published under exclusive license to Japanese Society of Gastroenterology.
AB - The article ‘Efficacy of liposomal irinotecan + 5‑FU/LV vs. S‑1 in gemcitabine‑refractory metastatic pancreatic cancer: a real‑world study using inverse probability of treatment weighting’, written by ‘Hiroshi Imaoka, Masafumi Ikeda, Satoshi Kobayashi, Akihiro Ohba, Masayuki Ueno, Yuko Suzuki, Hidetaka Tsumura, Nana Kimura, Shinya Kawaguchi, Yasuyuki Kawamoto, Kohei Nakachi, Kunihiro Tsuji, Noritoshi Kobayashi, Reiko Ashida, Naohiro Okano, Kumiko Umemoto, Gou Murohisa, Ayumu Hosokawa, Akinori Asagi, Hiroko Nebiki, Rei Suzuki, Takeshi Terashima, Ryusuke Shibata, Kazuhito Kawata, Toshifumi Doi, Hiroshi Ohyama, Yohei Kitano, Kazuhiko Shioji, Hiroyuki Okuyama, Atsushi Naganuma, Yuji Negoro, Yasunari Sakamoto, Satoshi Shimizu, Chigusa Morizane, Makoto Ueno, Junji Furuse, Hiroaki Nagano, the Japan Oncology Network in Hepatobiliary and Pancreas’, was originally published under exclusive license to Japanese Society of Gastroenterology.
UR - http://www.scopus.com/inward/record.url?scp=85217564262&partnerID=8YFLogxK
U2 - 10.1007/s00535-025-02215-1
DO - 10.1007/s00535-025-02215-1
M3 - コメント/討論
C2 - 39878838
AN - SCOPUS:85217564262
SN - 0944-1174
JO - Journal of Gastroenterology
JF - Journal of Gastroenterology
ER -
